Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
256.45
Dollar change
-8.44
Percentage change
-3.19
%
Index- P/E- EPS (ttm)-2.17 Insider Own4.26% Shs Outstand129.29M Perf Week-7.15%
Market Cap33.20B Forward P/E313.92 EPS next Y0.82 Insider Trans-1.67% Shs Float123.92M Perf Month2.17%
Income-278.16M PEG- EPS next Q-0.94 Inst Own95.36% Short Float2.38% Perf Quarter-4.65%
Sales2.25B P/S14.77 EPS this Y22.44% Inst Trans3.54% Short Ratio4.26 Perf Half Y-2.45%
Book/sh0.52 P/B494.24 EPS next Y148.32% ROA-6.84% Short Interest2.94M Perf Year58.30%
Cash/sh20.81 P/C12.32 EPS next 5Y- ROE- 52W Range141.98 - 304.39 Perf YTD8.98%
Dividend Est.- P/FCF- EPS past 5Y23.11% ROI-10.47% 52W High-15.75% Beta0.37
Dividend TTM- Quick Ratio2.71 Sales past 5Y63.53% Gross Margin85.62% 52W Low80.63% ATR (14)9.36
Dividend Ex-Date- Current Ratio2.78 EPS Y/Y TTM38.54% Oper. Margin-7.87% RSI (14)42.86 Volatility3.54% 3.49%
Employees2230 Debt/Eq40.89 Sales Y/Y TTM22.97% Profit Margin-12.37% Recom1.88 Target Price304.65
Option/ShortYes / Yes LT Debt/Eq38.58 EPS Q/Q40.90% Payout- Rel Volume1.08 Prev Close264.89
Sales Surprise1.81% EPS Surprise-9.78% Sales Q/Q34.90% EarningsFeb 13 BMO Avg Volume690.64K Price256.45
SMA20-5.32% SMA500.56% SMA2006.53% Trades Volume748,382 Change-3.19%
Date Action Analyst Rating Change Price Target Change
Nov-12-24Downgrade Wolfe Research Peer Perform → Underperform
Oct-16-24Initiated Scotiabank Sector Outperform
Aug-16-24Upgrade Goldman Neutral → Buy $198 → $370
Feb-16-24Downgrade Goldman Buy → Neutral $173
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-08-23Initiated Wells Fargo Equal Weight $171
Dec-08-23Initiated Wells Fargo Equal Weight
Oct-11-23Downgrade Oppenheimer Outperform → Perform
Sep-29-23Initiated Raymond James Outperform $208
May-05-23Upgrade BMO Capital Markets Market Perform → Outperform $200 → $250
Feb-14-25 04:35PM
02:10AM
Feb-13-25 11:26PM
09:30AM
09:15AM
08:18AM Loading…
08:18AM
08:00AM
Feb-10-25 09:16AM
Feb-06-25 10:01AM
Jan-30-25 08:00AM
Jan-23-25 09:50AM
Jan-21-25 07:20PM
09:40AM
Jan-12-25 04:00PM
Jan-06-25 08:00AM
09:40AM Loading…
Dec-25-24 09:40AM
Dec-23-24 10:09AM
Dec-04-24 12:00PM
Dec-02-24 02:48PM
Nov-27-24 07:00AM
05:38AM
Nov-25-24 04:16PM
07:00AM
Nov-22-24 02:16PM
Nov-18-24 07:24AM
Nov-17-24 09:30AM
Nov-15-24 07:19PM
Nov-06-24 12:26PM
04:27AM
Nov-04-24 08:00AM
10:34AM Loading…
Nov-01-24 10:34AM
03:05AM
01:11AM
12:25AM
Oct-31-24 10:00AM
09:10AM
08:07AM
08:00AM
Oct-30-24 11:31AM
08:00AM
Oct-28-24 09:16AM
Oct-24-24 10:01AM
Oct-23-24 12:00PM
Oct-17-24 09:40AM
08:00AM
Oct-16-24 08:00AM
Oct-09-24 12:14PM
07:00AM
07:00AM
Oct-08-24 07:41AM
Oct-07-24 03:00AM
Oct-01-24 09:40AM
08:03AM
Sep-29-24 09:00AM
Sep-26-24 08:00AM
Sep-14-24 07:03PM
Sep-13-24 07:10PM
Sep-12-24 01:01PM
Sep-08-24 02:01AM
Sep-06-24 07:09PM
Aug-30-24 04:19PM
04:03PM
02:33PM
02:33PM
10:13AM
06:00AM
02:00AM
Aug-28-24 04:00PM
Aug-23-24 10:22AM
Aug-21-24 02:45AM
Aug-07-24 09:00AM
08:00AM
Aug-04-24 06:55PM
Aug-02-24 09:45AM
06:39AM
01:03AM
Aug-01-24 07:25PM
11:30AM
09:15AM
08:14AM
08:00AM
Jul-30-24 09:15AM
Jul-25-24 10:01AM
Jul-18-24 08:00AM
06:05AM
Jul-11-24 06:30AM
Jul-09-24 06:00AM
Jul-08-24 04:52AM
Jul-05-24 03:01PM
Jun-25-24 07:45PM
08:59AM
Jun-24-24 09:41PM
04:11PM
01:54PM
01:54PM
01:05PM
12:52PM
12:42PM
12:32PM
10:53AM
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Garg PushkalCMO & EVP Dev & Med AffairsJan 27 '25Option Exercise88.9548,8764,347,52064,581Jan 29 04:03 PM
Garg PushkalCMO & EVP Dev & Med AffairsJan 27 '25Sale285.0052,59214,988,72011,989Jan 29 04:03 PM
Garg PushkalOfficerJan 27 '25Proposed Sale285.0052,59214,988,720Jan 27 04:01 PM
SHARP PHILLIP ADirectorJan 23 '25Option Exercise131.2111,2501,476,11211,250Jan 24 04:10 PM
SHARP PHILLIP ADirectorJan 23 '25Sale275.0011,2503,093,7500Jan 24 04:10 PM
SHARP PHILLIP ADirectorJan 23 '25Proposed Sale275.0011,2503,093,750Jan 23 04:17 PM
Garg PushkalCMO & EVP Dev & Med AffairsDec 12 '24Sale251.001,752439,76015,705Dec 13 04:13 PM
Garg PushkalOfficerDec 12 '24Proposed Sale255.021,752446,795Dec 12 04:05 PM
Greenstreet YvonneChief Executive OfficerNov 26 '24Sale250.985,2191,309,85378,880Nov 27 05:22 PM
Garg PushkalCMO & EVP Dev & Med AffairsNov 26 '24Sale250.981,682422,14417,457Nov 27 05:22 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerNov 26 '24Sale250.981,682422,14430,644Nov 27 05:21 PM
Tanguler TolgaEVP, Chief Commercial OfficerNov 26 '24Sale250.981,469368,68613,191Nov 27 05:21 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchNov 27 '24Sale252.291,531386,26112,881Nov 27 05:20 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchNov 26 '24Sale250.981,469368,68614,412Nov 27 05:20 PM
Fitzgerald Kevin JosephOfficerNov 27 '24Proposed Sale253.981,531388,843Nov 27 04:06 PM
Greenstreet YvonneChief Executive OfficerAug 20 '24Option Exercise85.0015,0001,275,00088,441Aug 22 08:01 PM
Greenstreet YvonneChief Executive OfficerAug 20 '24Sale280.0015,0004,200,00073,441Aug 22 08:01 PM
Greenstreet YvonneOfficerAug 20 '24Proposed Sale280.0015,0004,200,000Aug 20 05:10 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchAug 12 '24Option Exercise89.0920,7251,846,42934,906Aug 14 04:12 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchAug 12 '24Sale270.9922,0255,968,51612,881Aug 14 04:12 PM
Fitzgerald Kevin JosephOfficerAug 12 '24Proposed Sale269.5222,0255,936,178Aug 12 04:07 PM
Ausiello Dennis ADirectorAug 06 '24Option Exercise119.6820,2502,423,45220,386Aug 08 04:10 PM
Ausiello Dennis ADirectorAug 06 '24Sale262.0020,2505,305,586136Aug 08 04:10 PM
Ausiello Dennis ADirectorAug 06 '24Proposed Sale266.6620,2505,399,865Aug 06 04:07 PM
Greenstreet YvonneChief Executive OfficerAug 01 '24Option Exercise85.0015,1481,287,58088,589Aug 02 08:01 PM
Greenstreet YvonneChief Executive OfficerAug 01 '24Sale270.0015,1484,089,96073,441Aug 02 08:01 PM
Greenstreet YvonneOfficerAug 01 '24Proposed Sale270.0015,1484,089,960Aug 01 04:01 PM
Greenstreet YvonneChief Executive OfficerJul 11 '24Sale261.007,0931,851,27373,441Jul 12 08:02 PM
SCHULMAN AMY WDirectorJun 25 '24Option Exercise131.218,5001,115,28516,936Jun 27 04:04 PM
SCHULMAN AMY WDirectorJun 25 '24Sale240.008,5002,040,0008,436Jun 27 04:04 PM
PYOTT DAVID E IDirectorJun 24 '24Option Exercise80.7632,4502,620,61132,586Jun 26 04:28 PM
PYOTT DAVID E IDirectorJun 24 '24Sale220.6932,4507,161,360136Jun 26 04:28 PM
Garg PushkalCMO & EVP Dev & Med AffairsJun 25 '24Sale230.992,103485,77315,609Jun 26 04:28 PM
Greenstreet YvonneChief Executive OfficerJun 25 '24Sale230.998,3011,917,47580,534Jun 26 04:27 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerJun 25 '24Sale231.001,605370,74728,892Jun 26 04:26 PM
Tanguler TolgaEVP, Chief Commercial OfficerJun 25 '24Sale231.001,605370,74711,660Jun 26 04:26 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchJun 25 '24Sale230.991,198276,73114,181Jun 26 04:26 PM
SCHULMAN AMY WDirectorMay 29 '24Option Exercise66.8330,0002,004,90030,136May 31 07:00 PM
SCHULMAN AMY WDirectorMay 29 '24Sale148.6021,7003,224,5468,436May 31 07:00 PM
SHARP PHILLIP ADirectorFeb 29 '24Option Exercise59.2530,0001,777,50030,000Mar 01 04:12 PM
SHARP PHILLIP ADirectorFeb 29 '24Sale151.3430,0004,540,0710Mar 01 04:12 PM
Tanguler TolgaEVP, Chief Commercial OfficerFeb 27 '24Option Exercise0.001,66705,737Feb 29 04:18 PM
Tanguler TolgaEVP, Chief Commercial OfficerFeb 28 '24Sale155.3050177,8055,236Feb 29 04:18 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerFeb 27 '24Option Exercise0.001,908020,052Feb 29 04:18 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerFeb 28 '24Sale155.3057489,14519,478Feb 29 04:18 PM
Greenstreet YvonneChief Executive OfficerFeb 27 '24Option Exercise0.005,921051,060Feb 29 04:18 PM
Greenstreet YvonneChief Executive OfficerFeb 28 '24Sale155.312,932455,35748,128Feb 29 04:18 PM
Garg PushkalCMO & EVP Dev & Med AffairsFeb 27 '24Option Exercise0.001,90809,240Feb 29 04:17 PM
Garg PushkalCMO & EVP Dev & Med AffairsFeb 28 '24Sale155.3057489,1458,666Feb 29 04:17 PM
Franchini Indrani LallEVP, CLO & SecretaryFeb 27 '24Option Exercise0.0087804,462Feb 29 04:16 PM
Franchini Indrani LallEVP, CLO & SecretaryFeb 28 '24Sale155.3032951,0944,133Feb 29 04:16 PM